About the Company
We do not have any company description for Krystal Biotech, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Krystal Biotech, Inc.
A Glimpse Into The Expert Outlook On Krystal Biotech Through 10 Analysts
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $209.8, a high estimate of $240.00, and a low estimate of $166.00. A negative shift in sentiment ...
Krystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung Cancer
Based on promising early evidence of efficacy in the treatment of non-small cell lung cancer (NSCLC), the Company was granted an End of Phase 2 meeting with the United States Food and Drug ...
Krystal Biotech, Inc. (NASDAQ:KRYS) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 4, 2025 Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $1.29, ...
Krystal Biotech, Inc. (NASDAQ:KRYS) Just Released Its Third-Quarter ...
It's been a good week for Krystal Biotech, Inc. (NASDAQ:KRYS) shareholders, because the company has just released its latest quarterly results, and the shares gained 4.3% to US$183.
Krystal Biotech Inc (KRYS) Q1 2025 Earnings Report Preview: What to ...
Krystal Biotech Inc (NASDAQ:KRYS) is set to release its Q1 2025 earnings on May 6, 2025. The consensus estimate for Q1 2025 revenue is $96.24 million, and the earnings are expected to come in at ...
Krystal Biotech, Inc. (KRYS) Tops Q2 Earnings and Revenue Estimates
Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $0.86 per share a year ago.
Krystal Biotech Analysts Increase Their Forecasts Following Q4 Results
Krystal Biotech, Inc. KRYS reported better-than-expected financial results for its fourth quarter on Monday. Krystal Biotech posted quarterly earnings of 30 cents per share, compared to market ...
Krystal Biotech, Inc. (KRYS) Q4 2023 Earnings Call Transcript
Krystal Biotech, Inc. (NASDAQ: KRYS) Q4 2023 Earnings Call Transcript February 26, 2024 8:30 AM ET Company Participants Meg Dodge - Head of IR & Corporate Communications Krish Krishnan - Chairman ...
Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings Call Transcript
Krystal Biotech, Inc. (NASDAQ:KRYS) Q1 2024 Earnings Conference Call May 6, 2024 8:30 AM ETCompany ParticipantsStéphane Paquette - VP, Business ...
A Krystal Biotech, Inc. (NASDAQ:KRYS) insider lowered their holding by ...
Krystal Biotech Insider Transactions Over The Last Year In the last twelve months, the biggest single sale by an insider was when the Lead Independent Director, Daniel Janney, sold US$7.1m worth ...
Similar Companies
Loading the latest forecasts...